Synchron CEO on first FDA approved brain chip implant for paralysis
Synchron CEO Dr. Thomas Oxley on receiving FDA approval for clinical trials in the U.S. and discusses the benefits of his company's brain-computer interface device.
Friday, July 30, 2021
Synchron CEO on first FDA approved brain chip implant for paralysis
Synchron CEO on first FDA approved brain chip implant for paralysis
Synchron CEO Dr. Thomas Oxley on receiving FDA approval for clinical trials in the U.S. and discusses the benefits of his company's brain-computer interface device.
Related Posts:
Exclusive: Fed could raise rates as much as twice this year - BlackRock's Rieder- Germany ready to buy company stakes to safeguard under-threat industry
- Exclusive: Indian steel firms seek higher duties on steel imports as prices drop
- German minister: Clear rules apply to all providers in building 5G network
- Populists will always find ways to shame the rich: Kennedy
0 comments:
Post a Comment